Eurand Announces Conference Call on Second Quarter 2008 Financial Results
Eurand Industrial Award Honors Achievement
Eurand Names Bill Newbould Vice President, Investor Relations
Eurand Receives Approvable Letter from FDA for EUR-1008 (Zentase™)
Eurand To Be Issued U.S. Patent for Amrix®
Eurand to Present at UBS Global Specialty and Generic Pharmaceuticals Conference
Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008
Eurand Reports First Quarter 2008 Key Achievements and Financial Results
Eurand to Present at Upcoming Conferences
Eurand Announces Launch of OTC Unisom® SleepMelts by Chattem